Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $1,912,350 were sold by Hoge Stephen on May 15 ’24. At $127.49 per share, Hoge Stephen sold 15,000 shares. The insider’s holdings dropped to 1,471,508 shares worth approximately $241.34 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, AFEYAN NOUBAR sold 15,000 shares, netting a total of over 1,909,863 in proceeds. Following the sale of shares at $127.32 each, the insider now holds 1,996,931 shares.
Before that, Hoge Stephen had sold 255 shares from its account. In a trade valued at $30,844, the President traded Moderna Inc shares for $120.96 each. Upon closing the transaction, the insider’s holdings decreased to 255 shares, worth approximately $243.8 million.
As published in a research note from HSBC Securities on February 26, 2024, Moderna Inc [MRNA] has been rated down from a Hold to a Reduce and the price target has been revised to $86 from $75. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in early January. As of November 29, 2023, Canaccord Genuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA stock which previously was a “a Reduce”.
Analyzing MRNA Stock Performance
During the last five days, there has been a surge of approximately 23.61%. Over the course of the year, Moderna Inc shares have jumped approximately 64.92%. Shares of the company reached a 52-week high of $165.14 on 05/23/24 and a 52-week low of $84.06 on 02/13/24. A 50-day SMA is recorded $114.31, while a 200-day SMA reached $99.70. Nevertheless, trading volume fell to 7.11 million shares from 3.38 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 159.27, which, if violated, would cause prices to drop to 154.52. In the upper region, resistance lies at 166.95. The next price resistance is at 169.88. RSI (Relative Strength Index) is 85.64 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 23.74, which suggests the price will increase in the coming days. Percent R is at 2.33%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
